Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells.
Animals
Carcinoma, Squamous Cell
/ metabolism
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cytokines
/ metabolism
Gene Expression Regulation, Neoplastic
Humans
Keratinocytes
/ metabolism
Lymphatic Metastasis
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Mouth Neoplasms
/ metabolism
Neoplasm Invasiveness
Prognosis
Proteomics
Ubiquitins
/ metabolism
rac1 GTP-Binding Protein
/ metabolism
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
07
05
2018
accepted:
23
01
2019
revised:
15
12
2018
pubmed:
16
2
2019
medline:
31
12
2019
entrez:
16
2
2019
Statut:
ppublish
Résumé
In an effort to understand the underlying mechanisms of lymph node metastasis in oral squamous cell carcinoma (OSCC), through in vivo selection, LN1-1 cells were previously established from OEC-M1 cells and showed enhanced lymphangiogenesis and lymphatic metastasis capabilities. In the current study, we use a stable isotope labeling with amino acids in cell culture (SILAC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomic platform to compare LN1-1 to OEC-M1 cells. Interferon-stimulated gene 15 (ISG15) was found highly expressed in LN1-1 cells. Immunohistochemical analysis and meta-analysis of publicly available microarray datasets revealed that the ISG15 level was increased in human OSCC tissues and associated with poor disease outcome. Knockdown of ISG15 had minimal effects on tumor growth but did decrease tumor lymphangiogenesis and lymphatic metastasis of LN1-1 cells. Consistent with the in vivo assay, ISG15 knockdown did not impair cell growth but diminished cell migration, invasion, and transendothelial migration in vitro. ISG15-induced cell migration was independent of ISGylation and associated with membrane protrusion. Ectopic expression of ISG15 increased Rac1 activity and knockdown of Rac1 impaired ISG15-enhanced migration. Furthermore, Rac1 colocalized with ISG15 to a region of membrane protrusion and ISG15 coimmunoprecipitated with Rac1, especially with the Rac1-GDP form. Importantly, as shown by proximity ligation assays, ISG15 and Rac1 physically interacted with each other. Our results indicated that ISG15 affects cell migration by interacting with Rac1 and regulating Rac1 activity and contributes to lymphatic metastasis in OSCC.
Identifiants
pubmed: 30765861
doi: 10.1038/s41388-019-0731-8
pii: 10.1038/s41388-019-0731-8
doi:
Substances chimiques
Cytokines
0
RAC1 protein, human
0
Ubiquitins
0
ISG15 protein, human
60267-61-0
rac1 GTP-Binding Protein
EC 3.6.5.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4480-4495Références
Int J Cancer. 2019 Jun 1;144(11):2795-2810
pubmed: 30485433
Cancer Res. 2008 Jan 15;68(2):476-82
pubmed: 18199542
PLoS One. 2011;6(8):e23452
pubmed: 21853135
Nat Cell Biol. 2010 Nov;12(11):1078-85
pubmed: 20935639
Cancer Res. 2005 Apr 15;65(8):3063-71
pubmed: 15833835
Cancer Res. 2007 Aug 15;67(16):7589-96
pubmed: 17699762
BMC Cancer. 2009 Jan 12;9:11
pubmed: 19138406
Exp Biol Med (Maywood). 2012 Jan;237(1):38-49
pubmed: 22185919
Exp Ther Med. 2017 Sep;14(3):2329-2334
pubmed: 28962163
Oncotarget. 2015 Dec 8;6(39):41837-55
pubmed: 26540630
Methods Mol Biol. 2014;1188:351-64
pubmed: 25059623
Methods Mol Biol. 2012;832:141-9
pubmed: 22350882
PLoS One. 2013 Jul 24;8(7):e69389
pubmed: 23894465
Biochim Biophys Acta. 2010 May;1802(5):485-96
pubmed: 20153823
J Pathol. 2013 Jul;230(3):298-309
pubmed: 23362108
Mol Cancer. 2014 Jan 10;13:6
pubmed: 24410957
Oncotarget. 2015 Mar 30;6(9):7221-31
pubmed: 25749047
Cancer Res. 2014 Dec 15;74(24):7309-20
pubmed: 25368022
Cytokine Growth Factor Rev. 2006 Dec;17(6):411-21
pubmed: 17097911
Cancer Genet Cytogenet. 2004 Oct 1;154(1):27-35
pubmed: 15381369
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):764-71
pubmed: 18835509
J Cell Sci. 2016 Apr 1;129(7):1391-403
pubmed: 26872785
Semin Cancer Biol. 2012 Jun;22(3):234-49
pubmed: 22484561
Biochim Biophys Acta. 2007 May;1773(5):642-52
pubmed: 16926057
Neoplasia. 2007 Feb;9(2):166-80
pubmed: 17356713
Oncogene. 2013 Mar 28;32(13):1735-42
pubmed: 22614015
Nature. 2015 Jan 1;517(7532):89-93
pubmed: 25307056
Mol Cell Biol. 2006 Jan;26(2):472-9
pubmed: 16382139
Nat Cell Biol. 2012 Aug;14(8):777-83
pubmed: 22854810
Asian Pac J Cancer Prev. 2013;14(2):1147-50
pubmed: 23621203
Cancer Res. 2007 May 15;67(10):4605-19
pubmed: 17510386
Mol Biol Evol. 2007 Jan;24(1):203-16
pubmed: 17035353
Dev Cell. 2014 Jun 23;29(6):701-15
pubmed: 24960694
Stem Cells Int. 2016;2016:2809192
pubmed: 27057169
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Cytokine Growth Factor Rev. 2012 Dec;23(6):307-14
pubmed: 22906767
J Interferon Cytokine Res. 2017 Jun;37(6):246-253
pubmed: 28467275
Annu Rev Cell Dev Biol. 2010;26:315-33
pubmed: 19575647
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D115-9
pubmed: 14681372
Int J Mol Sci. 2012;13(9):11804-31
pubmed: 23109884
J Cell Biol. 2010 Aug 23;190(4):491-500
pubmed: 20733050
Trends Cell Biol. 2014 Apr;24(4):257-64
pubmed: 24284280
BMC Genomics. 2008 Feb 06;9:69
pubmed: 18254958
Oncotarget. 2016 Mar 29;7(13):16910-22
pubmed: 26919245
Proc Natl Acad Sci U S A. 1987 Sep;84(18):6394-8
pubmed: 3476954
Clin Cancer Res. 2013 Nov 1;19(21):5927-39
pubmed: 24056783
Curr Opin Cell Biol. 2014 Oct;30:60-7
pubmed: 24998184
Biochem Biophys Res Commun. 2014 May 23;448(1):95-100
pubmed: 24769207
Cancer. 2002 Oct 15;95(8):1663-72
pubmed: 12365014
Cell Mol Life Sci. 2004 Jun;61(11):1372-83
pubmed: 15170515
J Biol Chem. 1992 Apr 15;267(11):7806-13
pubmed: 1373138
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Oncotarget. 2014 Sep 30;5(18):8429-41
pubmed: 25238261
Nat Rev Mol Cell Biol. 2014 Dec;15(12):813-24
pubmed: 25355506
PLoS One. 2012;7(8):e43593
pubmed: 22937066
Trends Cell Biol. 2000 Oct;10(10):415-9
pubmed: 10998597
J Biol Chem. 1990 Jun 5;265(16):9373-80
pubmed: 2111820
ILAR J. 2002;43(4):244-58
pubmed: 12391400